Nasal Spray for Virus/SARS-COV-2 Reduction
A Canadian company has successfully run trials and tests to show that nitric oxide based nasal spray can reduce viral replication by 99.99% in 72 hours. Let’s look at this spray, the test results, and its mechanism of action for viruses.
Pre-read/watch
DrBeen’s discussion about N-AcetylCysteine
https://youtu.be/K8kKWgsGIU8
About Cysteine and Cystine
https://www.sciencedirect.com/topics/chemistry/sulfur-containing-amino-acid
saNotize nasal spray site.
https://sanotize.com/covid-19/
About NO
https://sanotize.com/why-nitric-oxide/
About neuraminidase inhibitors
https://en.wikipedia.org/wiki/Neuraminidase_inhibitor
About neuraminidase
https://en.wikipedia.org/wiki/Neuraminidase
About NO from Goodman Gillman for reference
Platelet activation and coagulation do not normally occur within an intact blood vessel. Thrombosis is prevented by several regulatory mechanisms that require healthy vascular endothelium. Nitric oxide and prostacyclin synthesized by endothelial cells inhibit platelet activation
Produced by activated helper T (TH) and natural killer (NK) cells, IFN-γ enhances the microbicidal activity of macrophages by inducing mammalian inducible nitric oxide synthase (iNOS, also called NOS2), thereby increasing their production of nitric oxide (NO) and their capacity to kill intracellular pathogens.
Brunton, Laurence; Knollman, Bjorn; Hilal-Dandan, Randa. Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition (Goodman and Gilman"S the Pharmacological Basis of Therapeutics) . McGraw-Hill Education. Kindle Edition.
Learning Objectives for Nasal Spray for SARS-COV-2 Virus Reduction
A few nasal sprays have shown efficacy in reducing viruses in the nasal epithelium. This session will review a nitric oxide-based nasal spray given authorization for SARS-COV-2 reduction in Israel and New Zealand.
Learning Objectives
No credit card information needed.
Write A New Comment
1 Comments
joan.roderick@*.com
Apr 22 2021, 4:15 pm
WOW!!